Top in ID: Interview with Fauci; clinicians explain why they chose ID

In an exclusive interview conducted during his final days in office, Anthony S. Fauci, MD, reflected on his time with the National Institute of Allergy and Infectious Diseases and what is next for him and the field of infectious disease.

“Just take a look at what COVID has done to the world. That’s the answer to how important the field of infectious disease is,” Fauci told Healio.

It was the top story in infectious disease last week.

Another top story was a series of submissions from clinicians who discussed why they are “hooked on ID.”

Read these and more top stories in infectious disease below:

Q&A: On eve of retirement from NIAID, Fauci tells Healio what’s next

At the end of this month, Fauci will officially step down as director of the National Institute of Allergy and Infectious Diseases, which he has led for nearly 4 decades. Read more.

‘My only regret is I cannot do it again’: Clinicians explain why they chose ID

We continue to be captivated by the stories you tell in our “Hooked on ID” series. Read more.

Severe outcomes most common in unvaccinated inpatients with delta variant COVID-19

The risk for severe disease or death among U.S. adults with COVID-19 was highest for unvaccinated inpatients and those infected with the delta variant, according to a recent study published in Clinical Infectious Diseases. Read more.

Mucosal vaccines for COVID-19 ‘should be developed and tested’

Experts argued for the development of COVID-19 vaccines that can be delivered at the site of infection but questioned whether it is possible to make a mucosal vaccine that prevents SARS-CoV-2 infection — and not just severe disease. Read more.

Malaria news you may have missed in 2022, including positive vaccine data

Malaria cases and deaths stabilized in 2021 after increasing in 2020 as the mosquito-borne disease took a back seat to COVID-19 and an exploding pandemic. Read more.